News FDA announces generative AI pilot and rapid rollout plans The FDA has completed a pilot of a new GenAI technology for speeding up drug reviews– And it wants to move from pilot to implementation in two months
Digital Generative AI in pharma: Moving beyond hype and into widespr... Generative AI (GenAI) has rapidly pushed its way to the forefront of tech innovation.
Digital Sponsored Creating True Value with GenAI Pharma companies are moving their Generative AI (GenAI) investments from pilot to production through exploration, experimentation, industrialisation/scaling, adoption, and monetisation.
Digital Sponsored Seven pillars of GenAI for enterprise-level value generation Today, we live in an age of artificial intelligence (AI); more specifically, the age of generative AI (GenAI).
Digital The art of software Harnessing the power of technology seems to be on the agenda for many life sciences companies these days.
Digital Sponsored AI in Medical Communications: Revolutionising the present, r... Artificial intelligence (AI) is poised to transform Medical Communications.
Oncology In pursuit of a cure for cancer: An ASCO 2025 discussion wit... Dr Danny Nguyen, medical oncologist and haematologist at the City of Hope Orange County, spoke with pharmaphorum at ASCO 2025.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face